Clinical Trial Update: Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tangningtongluo Tablet evaluating treatment for non-proliferative diabetic retinopathy in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tangningtongluo Tablet

Snippet

Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd | Conditions: Type2 Diabetes, Diabetic Retinopathy | Phase 2 | Status: UNKNOWN